Paul J. Hampel, M.D.

  1. Hematologist
  2. Hematologist / Oncologist

科室

  1. 血液科

专业团队

  1. CAR-T 细胞疗法计划
  2. 淋巴瘤团队
  3. 慢性淋巴增生性疾病小组

地点

  1. Rochester, Minnesota

语言

English

Paul Hampel, M.D., is a board-certified hematologist and oncologist specializing in lymphoproliferative diseases, including chronic lymphocytic leukemia, non-Hodgkin and Hodgkin lymphoma, hairy cell leukemia, and T-cell prolymphocytic leukemia.

Dr. Hampel has strong clinical and research interests in improving outcomes for patients with CLL and other lymphoproliferative diseases through a better understanding of resistance mechanisms to targeted therapeutics and optimal sequencing of treatment. He is involved in clinical research, including clinical trials and real-world outcomes research. As a member the laboratory of Dr. Esteban Braggio, Ph.D., Dr. Hampel is also collaboratively engaged in basic science research investigating the clonal heterogeneity and evolution of disease in patients with CLL.

  1. Chronic lymphocytic leukemia
  2. Hairy cell leukemia
  3. Hodgkin lymphoma
  4. Non-Hodgkin's lymphoma
  1. Cancer treatment
  2. CAR-T cell therapy
  3. Immunotherapy
  4. Targeted drug therapy
  • Chronic lymphocytic leukemia
  • Non-Hodgkin lymphoma
  • Hodgkin lymphoma
  • Hairy cell leukemia
  • T-cell prolymphocytic leukemia
  • Chimeric antigen receptor T-cell therapy
Rochester

Rochester, Minnesota
  1. 2022
    SubSpec FellowRST Hematology - Advanced, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  2. 2021
    FellowHematology/Oncology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  3. 2018
    ResidentInternal Medicine, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  4. 2015
    MDUniversity of Missouri School of Medicine
  5. 2011
    BS - BiologyUniversity of Missouri, Columbia

Certifications

  1. 2021
    Medical OncologyAmerican Board of Internal Medicine
  2. 2021
    HematologyAmerican Board of Internal Medicine
  3. 2018
    Internal MedicineAmerican Board of Internal Medicine

Awards and honors

  1. 2021
    Young Investigator Program GrantSociety of Hematologic Oncology
  2. 2021
    Young Investigator AwardConquer Cancer Foundation, American Society of Clinical Oncology
  3. 2021
    Angela and Anne V. Marinelli Endowed Fellowship Award, Mayo Clinic, Rochester, MNMayo Clinic
  4. 2019
    Top Rated AbstractInternational Workshop on Chronic Lymphocytic Leukemia (iwCLL)
  5. 2017
    ASH Abstract Achievement AwardAmerican Society of Hematology
  6. 2016
    National Cancer Research Institute 2016 Conference Prize AwardNational Cancer Research Institute (NCRI)
  7. 2016
    Attitude, Commitment, and Excellence (ACE) Award – PGY-2Internal Medicine Residency, Mayo Clinic School of Graduate Medical Education, Department of Education Administration
  8. 2015
    Attitude, Commitment, and Excellence (ACE) Award – PGY-1Internal Medicine Residency, Mayo Clinic School of Graduate Medical Education, Department of Education Administration
  9. 2015
    Medical Student Affairs Council, Class of 2015 Student Leadership and Service AwardUniversity of Missouri School of Medicine
  10. 2011
    Phi Beta Kappa Honors SocietyUniversity of Missouri, Columbia

Professional memberships

  1. 2021 - present
    MemberSociety of Hematologic Oncology
  2. 2019 - present
    MemberMature T-Cell Leukemia Interest Group
  3. 2019 - 2021
    MemberDivision of Hematology, Hematology Education and Program Evaluation Committee
  4. 2018 - 2019
    MemberMedical Oncology Clinical Practice Committee, Department of Oncology
  5. 2018 - present
    MemberAmerican Society of Hematology
  6. 2018 - present
    MemberAmerican Society of Clinical Oncology
  7. 2018 - present
    MemberEuropean Hematology Association